Portal Hypertension Assessment Crucial for Hepatocellular Carcinoma Resection Decision

Indirect signs of portal hypertension (pht) don’t raise complications risk in hepatocellular carcinoma (HCC) patients undergoing liver resection (LR). However, in patients with hepatic venous pressure gradient (HVPG) ≥10 mmHg, LR significantly increases overall morbidity and liver-related complications risk. Transjugular HVPG assessment is crucial for LR decisions, with a minimally invasive approach showing favorable outcomes, especially in HVPG ≥10 mmHg patients. Despite elevated risks, LR results in a 5-year overall survival rate of 55.2%.